PharVision Advisers’s Holley HLLY Stock Holding History

PharVision Advisers’s Portfolio HLLY Stock Details HLLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$65.6K	Buy	+21,381	New	+$81K	0.67%	79

Other funds holding HLLY

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CCG

Clearlake Capital Group Santa Monica, California $680M AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HIM

Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return

PharVision Advisers's HLLY Position: Q1 2026 in Review

PharVision Advisers opened a new position in Holley (HLLY) in Q1 2026: 21,381 shares worth $65.6K. The stake represents 0.67% of the portfolio and ranks #79 among its holdings.

140 funds tracked by Wall St. Rank hold HLLY as of Q1 2026.

PharVision Advisers held 21,381 shares of Holley worth $65.6K as of Q1 2026.
Holley was a new PharVision Advisers position in Q1 2026.
Holley made up 0.67% of PharVision Advisers's portfolio in Q1 2026, its #79 holding.
140 funds tracked by Wall St. Rank held Holley as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.